Leading drug makers seeking collaboration with multinational firms over OTC sales

With multinationals taking up three-quarters of the local prescription drug market, Korean drug companies are trying to survive the government’s price cuts by slashing production costs and collaborating with foreign companies to sell products.

Currently, foreign drug makers are poised to take a bigger share in domestic OTC markets predominated by local drug firms.

Bayer Healthcare is now...